Elanco to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 42^nd Annual J.P. Morgan Healthcare Conference on January 8-10, 2024. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts on Tuesday, January 9, 2024 at 3:00 p.m. PST (6:00 PM EST).

A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days.

ABOUT ELANCO

Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose– all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231219959132/en/

The Elanco Animal Health Stock at the time of publication of the news with a fall of -0,79 % to 12,52EUR on Tradegate stock exchange (18. Dezember 2023, 22:26 Uhr).